

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 8.44100814 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 8.44100814 |
| 3 | * signal peptide processing (GO:0006465) | 6.33619677 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.27331427 |
| 5 | protein retention in ER lumen (GO:0006621) | 5.50506762 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.39737199 |
| 7 | DNA deamination (GO:0045006) | 5.37224284 |
| 8 | protein maturation by protein folding (GO:0022417) | 5.20207763 |
| 9 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.70531964 |
| 10 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.68048068 |
| 11 | * SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.55495052 |
| 12 | sequestering of metal ion (GO:0051238) | 4.46891952 |
| 13 | * cotranslational protein targeting to membrane (GO:0006613) | 4.46727595 |
| 14 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.44770429 |
| 15 | ATP synthesis coupled proton transport (GO:0015986) | 4.44770429 |
| 16 | * protein targeting to ER (GO:0045047) | 4.43729070 |
| 17 | COPII vesicle coating (GO:0048208) | 4.40638989 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 4.36945128 |
| 19 | chaperone-mediated protein transport (GO:0072321) | 4.28632016 |
| 20 | * protein localization to endoplasmic reticulum (GO:0070972) | 4.27044383 |
| 21 | respiratory electron transport chain (GO:0022904) | 4.26949759 |
| 22 | protein complex biogenesis (GO:0070271) | 4.19848714 |
| 23 | * establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.19107177 |
| 24 | electron transport chain (GO:0022900) | 4.18962166 |
| 25 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.07697912 |
| 26 | GDP-mannose metabolic process (GO:0019673) | 4.06055773 |
| 27 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.05494350 |
| 28 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.99022277 |
| 29 | protein neddylation (GO:0045116) | 3.88920169 |
| 30 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.82556279 |
| 31 | NADH dehydrogenase complex assembly (GO:0010257) | 3.82556279 |
| 32 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.82556279 |
| 33 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.80247080 |
| 34 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.77857046 |
| 35 | CENP-A containing nucleosome assembly (GO:0034080) | 3.75579601 |
| 36 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.73633579 |
| 37 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.73633579 |
| 38 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.73353789 |
| 39 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.71704678 |
| 40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.71080384 |
| 41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.71080384 |
| 42 | chromatin remodeling at centromere (GO:0031055) | 3.69666501 |
| 43 | exocrine pancreas development (GO:0031017) | 3.67709927 |
| 44 | peptidyl-asparagine modification (GO:0018196) | 3.67349069 |
| 45 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.61095793 |
| 46 | DNA double-strand break processing (GO:0000729) | 3.58961824 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.56786204 |
| 48 | positive regulation of nuclease activity (GO:0032075) | 3.54255547 |
| 49 | termination of RNA polymerase III transcription (GO:0006386) | 3.53357476 |
| 50 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.53357476 |
| 51 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.52693181 |
| 52 | regulation of mitochondrial translation (GO:0070129) | 3.44606352 |
| 53 | positive regulation of ligase activity (GO:0051351) | 3.44595531 |
| 54 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.42974670 |
| 55 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.42484083 |
| 56 | protein N-linked glycosylation (GO:0006487) | 3.42481668 |
| 57 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.41657060 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.41080190 |
| 59 | rRNA modification (GO:0000154) | 3.39623660 |
| 60 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.37676672 |
| 61 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.35183642 |
| 62 | regulation of nuclease activity (GO:0032069) | 3.34065988 |
| 63 | secondary metabolite biosynthetic process (GO:0044550) | 3.33131512 |
| 64 | melanin biosynthetic process (GO:0042438) | 3.33031823 |
| 65 | histone exchange (GO:0043486) | 3.29931498 |
| 66 | regulation of cellular amine metabolic process (GO:0033238) | 3.27733123 |
| 67 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.27675034 |
| 68 | pseudouridine synthesis (GO:0001522) | 3.24535668 |
| 69 | platelet dense granule organization (GO:0060155) | 3.23780210 |
| 70 | endocrine pancreas development (GO:0031018) | 3.23383158 |
| 71 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.23300611 |
| 72 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.19287887 |
| 73 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.17201700 |
| 74 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.17201700 |
| 75 | proteasome assembly (GO:0043248) | 3.15752704 |
| 76 | cellular response to topologically incorrect protein (GO:0035967) | 3.15641246 |
| 77 | cellular response to unfolded protein (GO:0034620) | 3.15588520 |
| 78 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.15403394 |
| 79 | establishment of integrated proviral latency (GO:0075713) | 3.14758055 |
| 80 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.13137055 |
| 81 | protein targeting to mitochondrion (GO:0006626) | 3.12332321 |
| 82 | peptide hormone processing (GO:0016486) | 3.12316405 |
| 83 | ER overload response (GO:0006983) | 3.11647796 |
| 84 | DNA damage response, detection of DNA damage (GO:0042769) | 3.11491971 |
| 85 | regulation of ligase activity (GO:0051340) | 3.11033809 |
| 86 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.10495393 |
| 87 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.08907551 |
| 88 | glandular epithelial cell differentiation (GO:0002067) | 3.08054379 |
| 89 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.06954818 |
| 90 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.04628630 |
| 91 | * translation (GO:0006412) | 3.04439449 |
| 92 | protein deneddylation (GO:0000338) | 3.04039173 |
| 93 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.02963588 |
| 94 | maturation of 5.8S rRNA (GO:0000460) | 3.01163727 |
| 95 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.00762365 |
| 96 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.00116082 |
| 97 | cell redox homeostasis (GO:0045454) | 3.00045418 |
| 98 | viral transcription (GO:0019083) | 2.99118433 |
| 99 | protein localization to mitochondrion (GO:0070585) | 2.97798587 |
| 100 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.97542021 |
| 101 | vesicle coating (GO:0006901) | 2.95614684 |
| 102 | protein-cofactor linkage (GO:0018065) | 2.95156440 |
| 103 | translational termination (GO:0006415) | 2.93608511 |
| 104 | establishment of protein localization to mitochondrion (GO:0072655) | 2.92925070 |
| 105 | DNA ligation (GO:0006266) | 2.92079621 |
| 106 | ER-nucleus signaling pathway (GO:0006984) | 2.88716158 |
| 107 | cullin deneddylation (GO:0010388) | 2.88502220 |
| 108 | * protein targeting to membrane (GO:0006612) | 2.87743329 |
| 109 | oxidative phosphorylation (GO:0006119) | 2.87546378 |
| 110 | purine nucleobase biosynthetic process (GO:0009113) | 2.86837005 |
| 111 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.86707692 |
| 112 | spliceosomal snRNP assembly (GO:0000387) | 2.85970824 |
| 113 | positive regulation of cell cycle arrest (GO:0071158) | 2.85830541 |
| 114 | kinetochore assembly (GO:0051382) | 2.84043136 |
| 115 | melanin metabolic process (GO:0006582) | 2.83945722 |
| 116 | inner mitochondrial membrane organization (GO:0007007) | 2.83279468 |
| 117 | DNA replication checkpoint (GO:0000076) | 2.83025405 |
| 118 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.82043435 |
| 119 | negative regulation of protein ubiquitination (GO:0031397) | 2.80725479 |
| 120 | histone mRNA metabolic process (GO:0008334) | 2.80721278 |
| 121 | replication fork processing (GO:0031297) | 2.80329697 |
| 122 | DNA strand elongation (GO:0022616) | 2.79899522 |
| 123 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.79596368 |
| 124 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.79596368 |
| 125 | protein K6-linked ubiquitination (GO:0085020) | 2.78881866 |
| 126 | translational elongation (GO:0006414) | 2.78449983 |
| 127 | hydrogen ion transmembrane transport (GO:1902600) | 2.78300011 |
| 128 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.77091728 |
| 129 | kinetochore organization (GO:0051383) | 2.76705436 |
| 130 | telomere maintenance via recombination (GO:0000722) | 2.76521622 |
| 131 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.70895271 |
| 132 | lactate metabolic process (GO:0006089) | 2.70886681 |
| 133 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.70312729 |
| 134 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.70312729 |
| 135 | intracellular protein transmembrane import (GO:0044743) | 2.69302920 |
| 136 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.68580011 |
| 137 | DNA replication-independent nucleosome organization (GO:0034724) | 2.68580011 |
| 138 | rRNA methylation (GO:0031167) | 2.68510169 |
| 139 | mannosylation (GO:0097502) | 2.67569994 |
| 140 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.67446238 |
| 141 | cell cycle G1/S phase transition (GO:0044843) | 2.67446238 |
| 142 | establishment of viral latency (GO:0019043) | 2.66358256 |
| 143 | aldehyde catabolic process (GO:0046185) | 2.66220723 |
| 144 | response to endoplasmic reticulum stress (GO:0034976) | 2.64791264 |
| 145 | fatty acid elongation (GO:0030497) | 2.63610746 |
| 146 | respiratory chain complex IV assembly (GO:0008535) | 2.63263091 |
| 147 | protein K11-linked ubiquitination (GO:0070979) | 2.62959480 |
| 148 | proline biosynthetic process (GO:0006561) | 2.61191573 |
| 149 | nucleotide-sugar metabolic process (GO:0009225) | 2.58881209 |
| 150 | purine-containing compound salvage (GO:0043101) | 2.56123672 |
| 151 | GMP metabolic process (GO:0046037) | 2.54119388 |
| 152 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.53051766 |
| 153 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.50872149 |
| 154 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.49817174 |
| 155 | negative regulation of ligase activity (GO:0051352) | 2.49505987 |
| 156 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.49505987 |
| 157 | chaperone-mediated protein folding (GO:0061077) | 2.48493047 |
| 158 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.47910991 |
| 159 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.46251742 |
| 160 | response to unfolded protein (GO:0006986) | 2.45636393 |
| 161 | viral life cycle (GO:0019058) | 2.45413397 |
| 162 | response to topologically incorrect protein (GO:0035966) | 2.44423691 |
| 163 | ribosomal small subunit biogenesis (GO:0042274) | 2.43949509 |
| 164 | formation of translation preinitiation complex (GO:0001731) | 2.43827753 |
| 165 | peptidyl-histidine modification (GO:0018202) | 2.43041402 |
| 166 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.42716106 |
| 167 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.42716106 |
| 168 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.41723762 |
| 169 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.41723762 |
| 170 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.41723762 |
| 171 | translational initiation (GO:0006413) | 2.41289768 |
| 172 | maturation of SSU-rRNA (GO:0030490) | 2.41046659 |
| 173 | positive regulation of insulin secretion (GO:0032024) | 2.40705536 |
| 174 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.40574170 |
| 175 | iron-sulfur cluster assembly (GO:0016226) | 2.38661120 |
| 176 | metallo-sulfur cluster assembly (GO:0031163) | 2.38661120 |
| 177 | mitochondrial calcium ion transport (GO:0006851) | 2.38392789 |
| 178 | cytochrome complex assembly (GO:0017004) | 2.37940543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.05743294 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.98821638 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.90411447 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.63325029 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.56791465 |
| 6 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.54140964 |
| 7 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.44886955 |
| 8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.37319954 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.18216543 |
| 10 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.17318917 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.84429688 |
| 12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.84256790 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.70067086 |
| 14 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.65994873 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.65022566 |
| 16 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.56110884 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.54847674 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.51710775 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.44844138 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30880729 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.28671836 |
| 22 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25306724 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24287377 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.21218383 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.21152392 |
| 26 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.17865650 |
| 27 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.13720215 |
| 28 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.13646125 |
| 29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12482611 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.10859867 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.05767920 |
| 32 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.05553161 |
| 33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.04977620 |
| 34 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04484211 |
| 35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.03920706 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 2.02398357 |
| 37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.01971144 |
| 38 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.98445786 |
| 39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.93266901 |
| 40 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.93225139 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.89744621 |
| 42 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88063122 |
| 43 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.84751684 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79345877 |
| 45 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.79289731 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.78760710 |
| 47 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.75355640 |
| 48 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.74982122 |
| 49 | EWS_26573619_Chip-Seq_HEK293_Human | 1.69643041 |
| 50 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.69327161 |
| 51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.68431177 |
| 52 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.66101335 |
| 53 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65448081 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.62629825 |
| 55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.58529899 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58306609 |
| 57 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.57943642 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.57750977 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.56820024 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.56414022 |
| 61 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.56274592 |
| 62 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.55673661 |
| 63 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.52819446 |
| 64 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52252469 |
| 65 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52167877 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51606844 |
| 67 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.47966111 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47430242 |
| 69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.47207630 |
| 70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.45162127 |
| 71 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.43100204 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43042272 |
| 73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37964832 |
| 74 | MYC_22102868_ChIP-Seq_BL_Human | 1.35665714 |
| 75 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35578930 |
| 76 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.33887721 |
| 77 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31528891 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.30513754 |
| 79 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30223475 |
| 80 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27941340 |
| 81 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.27608511 |
| 82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.25526145 |
| 83 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.24395603 |
| 84 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23506712 |
| 85 | MYB_26560356_Chip-Seq_TH2_Human | 1.23093520 |
| 86 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.22168503 |
| 87 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.22146683 |
| 88 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.20699421 |
| 89 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18225797 |
| 90 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.15457771 |
| 91 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14051842 |
| 92 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.13550532 |
| 93 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12782794 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11278797 |
| 95 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.11153815 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.11076927 |
| 97 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10444486 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.10318232 |
| 99 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.10165805 |
| 100 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.09468691 |
| 101 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.08959255 |
| 102 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08733292 |
| 103 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.07951375 |
| 104 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07413171 |
| 105 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05149452 |
| 106 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.04585711 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04006492 |
| 108 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.03599432 |
| 109 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02556820 |
| 110 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02046447 |
| 111 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01726399 |
| 112 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01392801 |
| 113 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00793791 |
| 114 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.00374773 |
| 115 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99777816 |
| 116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99638757 |
| 117 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99051504 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98947064 |
| 119 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98680052 |
| 120 | MYB_26560356_Chip-Seq_TH1_Human | 0.97925019 |
| 121 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97542983 |
| 122 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.97463334 |
| 123 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.97385546 |
| 124 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.97321832 |
| 125 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95704229 |
| 126 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95483151 |
| 127 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.95032286 |
| 128 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93837314 |
| 129 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.93393116 |
| 130 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.91124740 |
| 131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90571458 |
| 132 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.90430259 |
| 133 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90395039 |
| 134 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90395039 |
| 135 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.89699638 |
| 136 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.89143488 |
| 137 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88884390 |
| 138 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.88684804 |
| 139 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.88684804 |
| 140 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.88340047 |
| 141 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87389648 |
| 142 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.87084302 |
| 143 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86117981 |
| 144 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.83781446 |
| 145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83275743 |
| 146 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.83016888 |
| 147 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.81975053 |
| 148 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.81975053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 3.66227191 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.17046587 |
| 3 | MP0003183_abnormal_peptide_metabolism | 3.15777929 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 3.10616938 |
| 5 | MP0005220_abnormal_exocrine_pancreas | 3.05034820 |
| 6 | MP0002693_abnormal_pancreas_physiology | 2.96980267 |
| 7 | MP0002102_abnormal_ear_morphology | 2.85331830 |
| 8 | MP0005171_absent_coat_pigmentation | 2.66011577 |
| 9 | MP0001944_abnormal_pancreas_morphology | 2.62075172 |
| 10 | MP0006054_spinal_hemorrhage | 2.58962257 |
| 11 | MP0003724_increased_susceptibility_to | 2.49572692 |
| 12 | MP0005671_abnormal_response_to | 2.38864822 |
| 13 | MP0001529_abnormal_vocalization | 2.34800956 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.32509299 |
| 15 | MP0001986_abnormal_taste_sensitivity | 2.31450328 |
| 16 | MP0003718_maternal_effect | 2.18803594 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.14842207 |
| 18 | MP0005379_endocrine/exocrine_gland_phen | 2.10359241 |
| 19 | MP0001984_abnormal_olfaction | 2.04190130 |
| 20 | MP0004043_abnormal_pH_regulation | 1.96552159 |
| 21 | MP0003195_calcinosis | 1.93142878 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.91938521 |
| 23 | MP0005253_abnormal_eye_physiology | 1.87733733 |
| 24 | MP0004957_abnormal_blastocyst_morpholog | 1.87492357 |
| 25 | MP0002736_abnormal_nociception_after | 1.87131760 |
| 26 | MP0004147_increased_porphyrin_level | 1.84540199 |
| 27 | MP0000678_abnormal_parathyroid_gland | 1.82405245 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.82376061 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.77812466 |
| 30 | MP0009785_altered_susceptibility_to | 1.74270034 |
| 31 | MP0003880_abnormal_central_pattern | 1.69620126 |
| 32 | MP0002090_abnormal_vision | 1.68202410 |
| 33 | MP0003866_abnormal_defecation | 1.65666825 |
| 34 | MP0000490_abnormal_crypts_of | 1.65611637 |
| 35 | MP0008877_abnormal_DNA_methylation | 1.65518062 |
| 36 | MP0003186_abnormal_redox_activity | 1.65410368 |
| 37 | MP0003111_abnormal_nucleus_morphology | 1.65168641 |
| 38 | MP0010386_abnormal_urinary_bladder | 1.64662903 |
| 39 | MP0009697_abnormal_copulation | 1.63640687 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.61978367 |
| 41 | MP0008007_abnormal_cellular_replicative | 1.61501869 |
| 42 | MP0003011_delayed_dark_adaptation | 1.61374366 |
| 43 | MP0003436_decreased_susceptibility_to | 1.55772604 |
| 44 | MP0003786_premature_aging | 1.54322070 |
| 45 | MP0008058_abnormal_DNA_repair | 1.53134230 |
| 46 | MP0005551_abnormal_eye_electrophysiolog | 1.50061418 |
| 47 | MP0000685_abnormal_immune_system | 1.49270549 |
| 48 | MP0005025_abnormal_response_to | 1.49078261 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.48200890 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.44954666 |
| 51 | MP0001324_abnormal_eye_pigmentation | 1.43783058 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.42972969 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.41524037 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.41102999 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.40185907 |
| 56 | MP0006035_abnormal_mitochondrial_morpho | 1.38930526 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.38926081 |
| 58 | MP0001819_abnormal_immune_cell | 1.37660108 |
| 59 | MP0000613_abnormal_salivary_gland | 1.37214418 |
| 60 | MP0002723_abnormal_immune_serum | 1.36564244 |
| 61 | MP0001905_abnormal_dopamine_level | 1.35375599 |
| 62 | MP0009379_abnormal_foot_pigmentation | 1.34858750 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.34264094 |
| 64 | MP0002419_abnormal_innate_immunity | 1.33907759 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.33282205 |
| 66 | MP0002933_joint_inflammation | 1.32953914 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.30901049 |
| 68 | MP0003890_abnormal_embryonic-extraembry | 1.30712622 |
| 69 | MP0002398_abnormal_bone_marrow | 1.29758115 |
| 70 | MP0003283_abnormal_digestive_organ | 1.29628624 |
| 71 | MP0000569_abnormal_digit_pigmentation | 1.29579441 |
| 72 | MP0008789_abnormal_olfactory_epithelium | 1.29154739 |
| 73 | MP0001800_abnormal_humoral_immune | 1.27288868 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.26237282 |
| 75 | MP0002452_abnormal_antigen_presenting | 1.26223849 |
| 76 | MP0005636_abnormal_mineral_homeostasis | 1.25094606 |
| 77 | MP0005408_hypopigmentation | 1.24121414 |
| 78 | MP0002405_respiratory_system_inflammati | 1.23462717 |
| 79 | MP0001764_abnormal_homeostasis | 1.23453546 |
| 80 | MP0005310_abnormal_salivary_gland | 1.23294730 |
| 81 | MP0009643_abnormal_urine_homeostasis | 1.23222779 |
| 82 | MP0009046_muscle_twitch | 1.21288087 |
| 83 | MP0002638_abnormal_pupillary_reflex | 1.20946934 |
| 84 | MP0000716_abnormal_immune_system | 1.20814346 |
| 85 | MP0001790_abnormal_immune_system | 1.19942290 |
| 86 | MP0005387_immune_system_phenotype | 1.19942290 |
| 87 | MP0003121_genomic_imprinting | 1.19346249 |
| 88 | MP0000647_abnormal_sebaceous_gland | 1.18326405 |
| 89 | MP0010155_abnormal_intestine_physiology | 1.18221211 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 1.16928759 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 1.16879633 |
| 92 | MP0003300_gastrointestinal_ulcer | 1.15219454 |
| 93 | MP0001968_abnormal_touch/_nociception | 1.13900610 |
| 94 | MP0004782_abnormal_surfactant_physiolog | 1.13408761 |
| 95 | MP0003077_abnormal_cell_cycle | 1.13313101 |
| 96 | MP0002429_abnormal_blood_cell | 1.12122222 |
| 97 | MP0000689_abnormal_spleen_morphology | 1.11073955 |
| 98 | MP0001666_abnormal_nutrient_absorption | 1.10740552 |
| 99 | MP0001293_anophthalmia | 1.10532011 |
| 100 | MP0000371_diluted_coat_color | 1.10093499 |
| 101 | MP0010094_abnormal_chromosome_stability | 1.09660787 |
| 102 | MP0000681_abnormal_thyroid_gland | 1.09566465 |
| 103 | MP0002722_abnormal_immune_system | 1.08921925 |
| 104 | MP0003172_abnormal_lysosome_physiology | 1.08634271 |
| 105 | MP0003567_abnormal_fetal_cardiomyocyte | 1.08616808 |
| 106 | MP0001533_abnormal_skeleton_physiology | 1.07448339 |
| 107 | MP0008872_abnormal_physiological_respon | 1.06468181 |
| 108 | MP0005174_abnormal_tail_pigmentation | 1.05961828 |
| 109 | MP0003868_abnormal_feces_composition | 1.05863194 |
| 110 | MP0001485_abnormal_pinna_reflex | 1.05647869 |
| 111 | MP0000372_irregular_coat_pigmentation | 1.05536565 |
| 112 | MP0002095_abnormal_skin_pigmentation | 1.05431778 |
| 113 | MP0002163_abnormal_gland_morphology | 1.04713772 |
| 114 | MP0006292_abnormal_olfactory_placode | 1.04252285 |
| 115 | MP0000858_altered_metastatic_potential | 1.03798308 |
| 116 | MP0008469_abnormal_protein_level | 1.03407038 |
| 117 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03275340 |
| 118 | MP0000703_abnormal_thymus_morphology | 1.03191430 |
| 119 | MP0001873_stomach_inflammation | 1.02934612 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 1.02087344 |
| 121 | MP0002928_abnormal_bile_duct | 1.00834112 |
| 122 | MP0005464_abnormal_platelet_physiology | 1.00159412 |
| 123 | MP0004142_abnormal_muscle_tone | 0.98288736 |
| 124 | MP0003806_abnormal_nucleotide_metabolis | 0.98143900 |
| 125 | MP0006072_abnormal_retinal_apoptosis | 0.96849903 |
| 126 | MP0008932_abnormal_embryonic_tissue | 0.96411568 |
| 127 | MP0004215_abnormal_myocardial_fiber | 0.90918350 |
| 128 | MP0000427_abnormal_hair_cycle | 0.90679976 |
| 129 | MP0001853_heart_inflammation | 0.90246370 |
| 130 | MP0003795_abnormal_bone_structure | 0.89904136 |
| 131 | MP0003959_abnormal_lean_body | 0.89878425 |
| 132 | MP0002751_abnormal_autonomic_nervous | 0.89854698 |
| 133 | MP0002019_abnormal_tumor_incidence | 0.89767507 |
| 134 | MP0001929_abnormal_gametogenesis | 0.89423416 |
| 135 | MP0002210_abnormal_sex_determination | 0.89204022 |
| 136 | MP0003943_abnormal_hepatobiliary_system | 0.88076120 |
| 137 | MP0002938_white_spotting | 0.87963069 |
| 138 | MP0002006_tumorigenesis | 0.87484714 |
| 139 | MP0002277_abnormal_respiratory_mucosa | 0.87268265 |
| 140 | MP0000358_abnormal_cell_content/ | 0.87137446 |
| 141 | MP0005365_abnormal_bile_salt | 0.87097217 |
| 142 | MP0004808_abnormal_hematopoietic_stem | 0.85837925 |
| 143 | MP0002132_abnormal_respiratory_system | 0.84162333 |
| 144 | MP0002272_abnormal_nervous_system | 0.82646748 |
| 145 | MP0001919_abnormal_reproductive_system | 0.82554169 |
| 146 | MP0005389_reproductive_system_phenotype | 0.82490747 |
| 147 | MP0002234_abnormal_pharynx_morphology | 0.81566315 |
| 148 | MP0005332_abnormal_amino_acid | 0.81319186 |
| 149 | MP0004133_heterotaxia | 0.80460756 |
| 150 | MP0009745_abnormal_behavioral_response | 0.80193824 |
| 151 | MP0005391_vision/eye_phenotype | 0.78901909 |
| 152 | MP0002160_abnormal_reproductive_system | 0.78434275 |
| 153 | MP0000653_abnormal_sex_gland | 0.78079082 |
| 154 | MP0002282_abnormal_trachea_morphology | 0.77950000 |
| 155 | MP0005394_taste/olfaction_phenotype | 0.77263666 |
| 156 | MP0005499_abnormal_olfactory_system | 0.77263666 |
| 157 | MP0005645_abnormal_hypothalamus_physiol | 0.76902530 |
| 158 | MP0000516_abnormal_urinary_system | 0.73915280 |
| 159 | MP0005367_renal/urinary_system_phenotyp | 0.73915280 |
| 160 | MP0000631_abnormal_neuroendocrine_gland | 0.73529207 |
| 161 | MP0004885_abnormal_endolymph | 0.71846924 |
| 162 | MP0005395_other_phenotype | 0.71352963 |
| 163 | MP0005410_abnormal_fertilization | 0.70794336 |
| 164 | MP0005187_abnormal_penis_morphology | 0.69510863 |
| 165 | MP0001145_abnormal_male_reproductive | 0.69235836 |
| 166 | MP0001186_pigmentation_phenotype | 0.68304630 |
| 167 | MP0006276_abnormal_autonomic_nervous | 0.67104175 |
| 168 | MP0001119_abnormal_female_reproductive | 0.64773852 |
| 169 | MP0003698_abnormal_male_reproductive | 0.63078301 |
| 170 | MP0002075_abnormal_coat/hair_pigmentati | 0.62953164 |
| 171 | MP0002233_abnormal_nose_morphology | 0.62436102 |
| 172 | MP0003123_paternal_imprinting | 0.60919684 |
| 173 | MP0008995_early_reproductive_senescence | 0.60762697 |
| 174 | MP0005195_abnormal_posterior_eye | 0.60323877 |
| 175 | MP0004924_abnormal_behavior | 0.57325248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type I transferrin isoform profile (HP:0003642) | 4.96512819 |
| 2 | Abnormal protein glycosylation (HP:0012346) | 4.56521539 |
| 3 | Abnormal glycosylation (HP:0012345) | 4.56521539 |
| 4 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 4.56521539 |
| 5 | Abnormal protein N-linked glycosylation (HP:0012347) | 4.56521539 |
| 6 | Progressive macrocephaly (HP:0004481) | 4.43916902 |
| 7 | Reduced antithrombin III activity (HP:0001976) | 4.08491853 |
| 8 | Increased hepatocellular lipid droplets (HP:0006565) | 4.00342547 |
| 9 | Hypoglycemic seizures (HP:0002173) | 3.86198561 |
| 10 | Hypoglycemic coma (HP:0001325) | 3.85269270 |
| 11 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.73095082 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.59726893 |
| 13 | Symptomatic seizures (HP:0011145) | 3.49712485 |
| 14 | Aplastic anemia (HP:0001915) | 3.44328472 |
| 15 | Cerebral edema (HP:0002181) | 3.35939466 |
| 16 | Generalized aminoaciduria (HP:0002909) | 3.35760209 |
| 17 | Thrombocytosis (HP:0001894) | 3.28259171 |
| 18 | Renal Fanconi syndrome (HP:0001994) | 3.25547629 |
| 19 | Methylmalonic acidemia (HP:0002912) | 3.00451016 |
| 20 | IgM deficiency (HP:0002850) | 2.99562560 |
| 21 | Late onset (HP:0003584) | 2.82856889 |
| 22 | Poor head control (HP:0002421) | 2.82652333 |
| 23 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.82284806 |
| 24 | Dysostosis multiplex (HP:0000943) | 2.79432233 |
| 25 | Abnormality of T cell physiology (HP:0011840) | 2.76612410 |
| 26 | Hepatic necrosis (HP:0002605) | 2.75517322 |
| 27 | Methylmalonic aciduria (HP:0012120) | 2.75238415 |
| 28 | Respiratory failure (HP:0002878) | 2.69367327 |
| 29 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.65093906 |
| 30 | Lactic acidosis (HP:0003128) | 2.64829965 |
| 31 | Abnormality of methionine metabolism (HP:0010901) | 2.64533871 |
| 32 | Increased serum pyruvate (HP:0003542) | 2.62947418 |
| 33 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.61453782 |
| 34 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.61453782 |
| 35 | Abnormality of the labia minora (HP:0012880) | 2.61376040 |
| 36 | Hypothermia (HP:0002045) | 2.61328473 |
| 37 | Degeneration of anterior horn cells (HP:0002398) | 2.61023363 |
| 38 | Abnormality of the anterior horn cell (HP:0006802) | 2.61023363 |
| 39 | 3-Methylglutaconic aciduria (HP:0003535) | 2.60960481 |
| 40 | Mucopolysacchariduria (HP:0008155) | 2.59829445 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.59829445 |
| 42 | Abnormality of glycolysis (HP:0004366) | 2.58967233 |
| 43 | Increased intramyocellular lipid droplets (HP:0012240) | 2.58378719 |
| 44 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.57982359 |
| 45 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.57982359 |
| 46 | Congenital, generalized hypertrichosis (HP:0004540) | 2.54706255 |
| 47 | Abnormality of the intrinsic pathway (HP:0010989) | 2.53664930 |
| 48 | Abnormal number of erythroid precursors (HP:0012131) | 2.51104133 |
| 49 | 11 pairs of ribs (HP:0000878) | 2.49346173 |
| 50 | Leukodystrophy (HP:0002415) | 2.48584704 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.45090329 |
| 52 | Exercise intolerance (HP:0003546) | 2.44604163 |
| 53 | Patchy hypopigmentation of hair (HP:0011365) | 2.43167379 |
| 54 | Pancreatic cysts (HP:0001737) | 2.42974750 |
| 55 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.42554084 |
| 56 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.42058646 |
| 57 | True hermaphroditism (HP:0010459) | 2.40694496 |
| 58 | Lethargy (HP:0001254) | 2.40132651 |
| 59 | Progressive neurologic deterioration (HP:0002344) | 2.39632047 |
| 60 | Exertional dyspnea (HP:0002875) | 2.39266380 |
| 61 | Pancreatic fibrosis (HP:0100732) | 2.38005432 |
| 62 | Beaking of vertebral bodies (HP:0004568) | 2.37457251 |
| 63 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.35512718 |
| 64 | Optic disc pallor (HP:0000543) | 2.35489852 |
| 65 | Recurrent bronchitis (HP:0002837) | 2.35432481 |
| 66 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.33331571 |
| 67 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.32352651 |
| 68 | Hyperglycinemia (HP:0002154) | 2.32348169 |
| 69 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.28081479 |
| 70 | Abnormality of T cells (HP:0002843) | 2.28010812 |
| 71 | Hepatocellular necrosis (HP:0001404) | 2.27093423 |
| 72 | B lymphocytopenia (HP:0010976) | 2.25192891 |
| 73 | Abnormality of B cell number (HP:0010975) | 2.25192891 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24963011 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24963011 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24963011 |
| 77 | Hypoplasia of the thymus (HP:0000778) | 2.22759390 |
| 78 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.20493117 |
| 79 | Molar tooth sign on MRI (HP:0002419) | 2.19989455 |
| 80 | Abnormality of midbrain morphology (HP:0002418) | 2.19989455 |
| 81 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.15665476 |
| 82 | Congenital primary aphakia (HP:0007707) | 2.15602152 |
| 83 | Meckel diverticulum (HP:0002245) | 2.15441473 |
| 84 | Gait imbalance (HP:0002141) | 2.11221541 |
| 85 | Abnormal pancreas size (HP:0012094) | 2.11124060 |
| 86 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.10824637 |
| 87 | Abnormality of serum amino acid levels (HP:0003112) | 2.08985436 |
| 88 | Chronic otitis media (HP:0000389) | 2.08350772 |
| 89 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.06610984 |
| 90 | Hypoplasia of the fovea (HP:0007750) | 2.06270314 |
| 91 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.06270314 |
| 92 | Increased muscle lipid content (HP:0009058) | 2.06116985 |
| 93 | Megaloblastic anemia (HP:0001889) | 2.05386131 |
| 94 | Abnormality of the ileum (HP:0001549) | 2.04794859 |
| 95 | Bronchitis (HP:0012387) | 2.04471632 |
| 96 | Short tibia (HP:0005736) | 2.04167360 |
| 97 | Abnormal lung lobation (HP:0002101) | 2.03449532 |
| 98 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.03275372 |
| 99 | Median cleft lip (HP:0000161) | 2.03259026 |
| 100 | Prominent metopic ridge (HP:0005487) | 2.02496154 |
| 101 | Abnormality of renal resorption (HP:0011038) | 2.01792247 |
| 102 | CNS demyelination (HP:0007305) | 2.01321508 |
| 103 | Mitochondrial inheritance (HP:0001427) | 1.99921927 |
| 104 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.99732178 |
| 105 | Microretrognathia (HP:0000308) | 1.99369848 |
| 106 | Abnormality of vitamin B metabolism (HP:0004340) | 1.98990538 |
| 107 | Neoplasm of the adrenal gland (HP:0100631) | 1.98660061 |
| 108 | Thoracolumbar scoliosis (HP:0002944) | 1.98642960 |
| 109 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.98370743 |
| 110 | Respiratory difficulties (HP:0002880) | 1.98359786 |
| 111 | Abnormality of chromosome stability (HP:0003220) | 1.98233800 |
| 112 | Nephrogenic diabetes insipidus (HP:0009806) | 1.98128821 |
| 113 | Intestinal atresia (HP:0011100) | 1.95603669 |
| 114 | Abnormality of the fovea (HP:0000493) | 1.94572919 |
| 115 | Eczematoid dermatitis (HP:0000976) | 1.93227528 |
| 116 | Large for gestational age (HP:0001520) | 1.93080594 |
| 117 | T lymphocytopenia (HP:0005403) | 1.91825982 |
| 118 | Irregular vertebral endplates (HP:0003301) | 1.89717162 |
| 119 | Severe visual impairment (HP:0001141) | 1.89686552 |
| 120 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.89614912 |
| 121 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.89601259 |
| 122 | Congenital stationary night blindness (HP:0007642) | 1.87865722 |
| 123 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87782290 |
| 124 | Recurrent abscess formation (HP:0002722) | 1.87274981 |
| 125 | Hyperglycemia (HP:0003074) | 1.86960442 |
| 126 | Renal cortical cysts (HP:0000803) | 1.86491056 |
| 127 | Reticulocytopenia (HP:0001896) | 1.85703699 |
| 128 | Myositis (HP:0100614) | 1.85195523 |
| 129 | White forelock (HP:0002211) | 1.84354231 |
| 130 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.84310778 |
| 131 | Abnormality of glycine metabolism (HP:0010895) | 1.84310778 |
| 132 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.83794437 |
| 133 | Acute necrotizing encephalopathy (HP:0006965) | 1.83769908 |
| 134 | Neutropenia (HP:0001875) | 1.83350947 |
| 135 | X-linked dominant inheritance (HP:0001423) | 1.80325602 |
| 136 | Bifid tongue (HP:0010297) | 1.80235050 |
| 137 | Genital tract atresia (HP:0001827) | 1.79752564 |
| 138 | Abnormality of T cell number (HP:0011839) | 1.78930847 |
| 139 | Microvesicular hepatic steatosis (HP:0001414) | 1.78531142 |
| 140 | Abnormality of the preputium (HP:0100587) | 1.78087916 |
| 141 | Supernumerary spleens (HP:0009799) | 1.77169721 |
| 142 | Decreased circulating renin level (HP:0003351) | 1.76898134 |
| 143 | Meningitis (HP:0001287) | 1.76492921 |
| 144 | Abnormality of urine glucose concentration (HP:0011016) | 1.76127171 |
| 145 | Glycosuria (HP:0003076) | 1.76127171 |
| 146 | Hypoplasia of the pons (HP:0012110) | 1.76093122 |
| 147 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.74610031 |
| 148 | Insulin resistance (HP:0000855) | 1.74235733 |
| 149 | Increased CSF lactate (HP:0002490) | 1.73985860 |
| 150 | Hyperphosphaturia (HP:0003109) | 1.72516088 |
| 151 | Adrenal hypoplasia (HP:0000835) | 1.72461049 |
| 152 | Vaginal atresia (HP:0000148) | 1.72256540 |
| 153 | Cerebral hypomyelination (HP:0006808) | 1.72116743 |
| 154 | Limb hypertonia (HP:0002509) | 1.71354306 |
| 155 | Colon cancer (HP:0003003) | 1.70837568 |
| 156 | Petechiae (HP:0000967) | 1.70300981 |
| 157 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.69437488 |
| 158 | Sparse eyelashes (HP:0000653) | 1.69268185 |
| 159 | Dicarboxylic aciduria (HP:0003215) | 1.68419051 |
| 160 | Ketoacidosis (HP:0001993) | 1.64644627 |
| 161 | Abnormality of the pons (HP:0007361) | 1.64074972 |
| 162 | IgG deficiency (HP:0004315) | 1.63988792 |
| 163 | Pancytopenia (HP:0001876) | 1.63543649 |
| 164 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.63192167 |
| 165 | Increased serum lactate (HP:0002151) | 1.62772512 |
| 166 | Conjugated hyperbilirubinemia (HP:0002908) | 1.61960929 |
| 167 | Recurrent viral infections (HP:0004429) | 1.61439735 |
| 168 | Lipid accumulation in hepatocytes (HP:0006561) | 1.60206058 |
| 169 | Progressive muscle weakness (HP:0003323) | 1.59540533 |
| 170 | Acute encephalopathy (HP:0006846) | 1.59267590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PASK | 3.83923924 |
| 2 | STK16 | 3.51961881 |
| 3 | EIF2AK3 | 3.25964051 |
| 4 | VRK2 | 2.96709115 |
| 5 | TRIM28 | 2.75168463 |
| 6 | EIF2AK1 | 2.74604027 |
| 7 | INSRR | 2.71370988 |
| 8 | ERN1 | 2.70158164 |
| 9 | FLT3 | 2.56034195 |
| 10 | TAOK3 | 2.51114889 |
| 11 | NEK1 | 2.47947172 |
| 12 | NME2 | 2.40672495 |
| 13 | MAPK15 | 2.32069855 |
| 14 | IRAK4 | 2.26266889 |
| 15 | BUB1 | 2.23854322 |
| 16 | WNK3 | 2.20344522 |
| 17 | IRAK3 | 2.15796393 |
| 18 | PLK3 | 2.14083762 |
| 19 | TEC | 2.07950753 |
| 20 | TESK2 | 2.05168292 |
| 21 | BCKDK | 1.99447054 |
| 22 | VRK1 | 1.82510368 |
| 23 | KDR | 1.81516116 |
| 24 | MAP4K2 | 1.80851694 |
| 25 | PLK2 | 1.77881115 |
| 26 | MAP4K1 | 1.76701939 |
| 27 | BCR | 1.73738892 |
| 28 | PDK2 | 1.72643799 |
| 29 | SCYL2 | 1.72281387 |
| 30 | ERBB3 | 1.69890932 |
| 31 | HIPK2 | 1.65161732 |
| 32 | TESK1 | 1.64949759 |
| 33 | TXK | 1.64019732 |
| 34 | ZAP70 | 1.63852881 |
| 35 | BTK | 1.45454990 |
| 36 | TTK | 1.44071360 |
| 37 | DYRK3 | 1.40844714 |
| 38 | PIM2 | 1.40039672 |
| 39 | ACVR1B | 1.39374131 |
| 40 | ZAK | 1.37887818 |
| 41 | BRSK2 | 1.36154375 |
| 42 | IRAK1 | 1.29245899 |
| 43 | RPS6KA4 | 1.25800866 |
| 44 | BLK | 1.24199063 |
| 45 | CSNK1G3 | 1.23856317 |
| 46 | NLK | 1.23547073 |
| 47 | JAK3 | 1.18772125 |
| 48 | TBK1 | 1.18745894 |
| 49 | CSNK1G2 | 1.15639680 |
| 50 | CSNK1G1 | 1.15073380 |
| 51 | WEE1 | 1.13273310 |
| 52 | KIT | 1.10233982 |
| 53 | PNCK | 1.10199936 |
| 54 | CDK8 | 1.09687575 |
| 55 | FRK | 1.04808754 |
| 56 | TLK1 | 1.04797823 |
| 57 | SRPK1 | 1.03908362 |
| 58 | GRK1 | 0.98207954 |
| 59 | ITK | 0.97928551 |
| 60 | IKBKE | 0.95731446 |
| 61 | DYRK2 | 0.95071899 |
| 62 | STK38L | 0.94148149 |
| 63 | MST4 | 0.92941863 |
| 64 | MAPK13 | 0.90572588 |
| 65 | NEK9 | 0.89959814 |
| 66 | MAPKAPK3 | 0.89068341 |
| 67 | CAMKK2 | 0.85791564 |
| 68 | PIK3CG | 0.85623788 |
| 69 | TGFBR1 | 0.83763122 |
| 70 | CASK | 0.83515749 |
| 71 | CSNK1A1L | 0.82687281 |
| 72 | TYK2 | 0.81833716 |
| 73 | LYN | 0.81308430 |
| 74 | TSSK6 | 0.79819545 |
| 75 | OXSR1 | 0.78450836 |
| 76 | IRAK2 | 0.78317728 |
| 77 | LIMK1 | 0.75621843 |
| 78 | BMPR1B | 0.74823013 |
| 79 | PBK | 0.74158077 |
| 80 | PRKCG | 0.73161962 |
| 81 | SYK | 0.73020377 |
| 82 | SIK3 | 0.72364171 |
| 83 | PLK4 | 0.70877586 |
| 84 | MKNK1 | 0.69960849 |
| 85 | YES1 | 0.69783398 |
| 86 | MKNK2 | 0.68727690 |
| 87 | PINK1 | 0.68485909 |
| 88 | EPHA3 | 0.67895906 |
| 89 | NME1 | 0.67468419 |
| 90 | MAP3K12 | 0.67234551 |
| 91 | PRKG2 | 0.66319942 |
| 92 | STK39 | 0.66290207 |
| 93 | TAF1 | 0.65901685 |
| 94 | MINK1 | 0.64966190 |
| 95 | MAP2K7 | 0.64092251 |
| 96 | LCK | 0.63610204 |
| 97 | AURKB | 0.60826378 |
| 98 | BRAF | 0.60711590 |
| 99 | PRKCE | 0.60145239 |
| 100 | PAK3 | 0.57272147 |
| 101 | DYRK1B | 0.55869639 |
| 102 | MAPKAPK5 | 0.55784196 |
| 103 | DAPK1 | 0.54604329 |
| 104 | MAP3K11 | 0.52115440 |
| 105 | STK3 | 0.51868328 |
| 106 | ATR | 0.51197747 |
| 107 | RPS6KB2 | 0.50262966 |
| 108 | CDC7 | 0.50199205 |
| 109 | MAP3K14 | 0.49182657 |
| 110 | ERBB4 | 0.48291578 |
| 111 | CSNK2A1 | 0.48250082 |
| 112 | CDK7 | 0.47473320 |
| 113 | CCNB1 | 0.47250361 |
| 114 | FER | 0.46658618 |
| 115 | ATM | 0.44790257 |
| 116 | CHEK2 | 0.44548286 |
| 117 | BRSK1 | 0.43981059 |
| 118 | MAP3K4 | 0.42959350 |
| 119 | TNIK | 0.42516534 |
| 120 | CSNK1A1 | 0.42431874 |
| 121 | CSK | 0.42172599 |
| 122 | GRK5 | 0.42135806 |
| 123 | CSF1R | 0.42033894 |
| 124 | FGFR2 | 0.41535494 |
| 125 | MAP3K1 | 0.40447522 |
| 126 | PAK4 | 0.40223588 |
| 127 | EIF2AK2 | 0.40145358 |
| 128 | AURKA | 0.39637097 |
| 129 | MARK3 | 0.38637319 |
| 130 | EPHA4 | 0.38424384 |
| 131 | PRKCI | 0.38389118 |
| 132 | CAMK2A | 0.38090935 |
| 133 | CDK3 | 0.37839510 |
| 134 | PLK1 | 0.37575026 |
| 135 | CSNK2A2 | 0.37491372 |
| 136 | ADRBK2 | 0.37202604 |
| 137 | RPS6KA5 | 0.36553849 |
| 138 | IKBKB | 0.36016624 |
| 139 | CHUK | 0.35916079 |
| 140 | LRRK2 | 0.34780902 |
| 141 | FES | 0.34527780 |
| 142 | CLK1 | 0.34287571 |
| 143 | MAP2K2 | 0.33545609 |
| 144 | PIM1 | 0.31789470 |
| 145 | MST1R | 0.30137514 |
| 146 | FGFR1 | 0.28769174 |
| 147 | NUAK1 | 0.28508637 |
| 148 | ILK | 0.27630546 |
| 149 | MAPKAPK2 | 0.27618101 |
| 150 | ADRBK1 | 0.27345521 |
| 151 | MYLK | 0.26923132 |
| 152 | CAMK2D | 0.26687069 |
| 153 | ABL2 | 0.26318414 |
| 154 | CDK14 | 0.26057017 |
| 155 | CDK18 | 0.25740922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Protein export_Homo sapiens_hsa03060 | 6.48176599 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.87576881 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.08065699 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.86210054 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.81868737 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.76261615 |
| 7 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.59196850 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.24529008 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.18544324 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.16735908 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.07825276 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.99754534 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86891124 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.86032299 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 1.82346400 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.75747010 |
| 17 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.73872764 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.72228093 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72138793 |
| 20 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.68967847 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.68862257 |
| 22 | Spliceosome_Homo sapiens_hsa03040 | 1.67085042 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.65453785 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63912195 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.59520442 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.57502426 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.52291461 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.50284201 |
| 29 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.48188852 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41431989 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.38712586 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.33800953 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30272615 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28815113 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.28241352 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.26318338 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22397220 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21975281 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.20708970 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.18919863 |
| 41 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.16027856 |
| 42 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.14544680 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13524861 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12344423 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.07900042 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 1.06583180 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.06203617 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04409196 |
| 49 | RNA transport_Homo sapiens_hsa03013 | 1.03200604 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02025910 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00485139 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99414357 |
| 53 | Basal transcription factors_Homo sapiens_hsa03022 | 0.98168416 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97192833 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96788902 |
| 56 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92847633 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90972548 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 0.90407377 |
| 59 | Cell cycle_Homo sapiens_hsa04110 | 0.86194752 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85312304 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.84862988 |
| 62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80584397 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76611192 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75024823 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74674122 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74121834 |
| 67 | Phototransduction_Homo sapiens_hsa04744 | 0.72030642 |
| 68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.71977223 |
| 69 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71877166 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70516086 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70258530 |
| 72 | Measles_Homo sapiens_hsa05162 | 0.69785215 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69749460 |
| 74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68794935 |
| 75 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68523586 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68086728 |
| 77 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.67704701 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67181991 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67112483 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65817002 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65677297 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65252516 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63653541 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62113790 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61555773 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61328659 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60777163 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58663801 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57443093 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57288128 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57167777 |
| 92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56953847 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55940111 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55078342 |
| 95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53194213 |
| 96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53026543 |
| 97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.52797479 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.51780868 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50921863 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.48615962 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47002559 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45143148 |
| 103 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45131797 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45115964 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.44424990 |
| 106 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42981676 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42006272 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41202840 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40325080 |
| 110 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38916931 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38496532 |
| 112 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37686290 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.35849570 |
| 114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.35070731 |
| 115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34634706 |
| 116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33575223 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.33150060 |
| 118 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32633666 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32487093 |
| 120 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32079328 |
| 121 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.30909997 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30224450 |
| 123 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.29164863 |
| 124 | Histidine metabolism_Homo sapiens_hsa00340 | 0.29027488 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28947254 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.27709588 |
| 127 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27709167 |
| 128 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27681668 |
| 129 | Allograft rejection_Homo sapiens_hsa05330 | 0.27141049 |
| 130 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.26119939 |
| 131 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.26036961 |
| 132 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.25565082 |
| 133 | Shigellosis_Homo sapiens_hsa05131 | 0.25558909 |
| 134 | Insulin secretion_Homo sapiens_hsa04911 | 0.25482985 |
| 135 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.24483776 |
| 136 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24055611 |
| 137 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23040567 |
| 138 | Apoptosis_Homo sapiens_hsa04210 | 0.22464753 |
| 139 | Hepatitis B_Homo sapiens_hsa05161 | 0.21895870 |
| 140 | Nicotine addiction_Homo sapiens_hsa05033 | 0.21587583 |
| 141 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.20618148 |
| 142 | Peroxisome_Homo sapiens_hsa04146 | 0.20512993 |
| 143 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20474446 |
| 144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20347101 |
| 145 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.18570101 |
| 146 | Influenza A_Homo sapiens_hsa05164 | 0.18517993 |

